TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Opthea ( (AU:OPT) ).
Opthea is a company operating in the pharmaceutical industry, focusing on developing critical medicines aimed at altering the course of devastating diseases. The company’s recent annual report highlights the inherent risks and bold strategies required in their industry to achieve these goals, emphasizing the importance of shareholder support in their mission.
The most recent analyst rating on (AU:OPT) stock is a Sell with a A$0.05 price target. To see the full list of analyst forecasts on Opthea stock, see the AU:OPT Stock Forecast page.
More about Opthea
YTD Price Performance: -25.93%
Technical Sentiment Signal: Sell
Current Market Cap: A$738.8M
For a thorough assessment of OPT stock, go to TipRanks’ Stock Analysis page.